Addyi was first authorised from the FDA in August 2015 to deal with hypoactive sexual motivation ailment (HSDD) in premenopausal women. That's just another way of saying it boosts intercourse push (also known as libido) in Women of all ages who have not reached menopause. It was the initial these drug authorised for this use. A 2nd dose of ulipr